The β2-subunit isoform is frequently amplified in a range of cancers, and as such, these results offer key mechanistic insight into how cancerous cells could leverage AMPK activity to provide a growth and survival advantage when faced with a nutrient-poor tumour microenvironment40. The gene discussed is PRKAA1; the disease is cancer.